用于CRISPR/Cas9核糖蛋白传递和基因编辑的精细调节的可离子化脂质纳米粒子
San Hae Im1, Mincheol Jang2, Ji-Ho Park3,4
1Department of Biological Sciences, Korea Advanced Institute of Science and Technology (KAIST), 291, Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.
Journal of nanobiotechnology
|April 12, 2024
概括
这项研究提出了一种新的脂质纳米粒子 (LNP) 配方,用于输送CRISPR/Cas9核糖蛋白 (RNP) 进行体内基因治疗. 这种有效的非病毒传递方法提高了癌细胞和瘤中的基因编辑效率.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 基因治疗 基因治疗
背景情况:
- 非病毒传递CRISPR/Cas9为体内基因疗法提供了优势,并降低了副作用风险.
- 在CRISPR/Cas9核糖蛋白 (RNP) 传递方面的挑战包括对组织和细胞进行体内基因编辑的弱准.
研究的目的:
- 为CRISPR/Cas9 RNPs开发一种有效的输送方法,使用可电离的脂质纳米颗粒 (LNP).
- 为了证明这些CRISPR/Cas9 RNP载荷LNP (CrLNP) 在体外和体外基因编辑的有效性.
主要方法:
- 对于CRISPR/Cas9 RNP传递来说,可电离性脂质纳米颗粒的配方优化.
- 在各种癌症细胞系中进行体外基因编辑效率评估.
- 在瘤组织中的体内输送和基因编辑疗效评估.
主要成果:
- 在多个癌症细胞系中,crlnps在体外表现出高基因编辑效率.
- 在体内观察到,CRLNP能有效地进入瘤组织.
- 在使用开发的CRLNP平台在体内实现了显著的基因编辑.
结论:
- 这项研究为CRISPR/Cas9 RNP交付提供了一个强大的非病毒平台.
- 这项技术对癌症和遗传疾病等疾病的体内基因编辑疗法具有前景.
相关概念视频
CRISPR
50.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.8K
CRISPR and crRNAs
17.0K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.0K


